Human CD4+ T-cell Epitope-based Therapeutic For Peanut Allergy
Funder
National Health and Medical Research Council
Funding Amount
$403,121.00
Summary
Peanut allergy affects ~2% of the population and peanuts are the major cause of fatal food-induced anaphylaxis. Peanut allergy usually appears in infancy and persists indefinitely. At present, unlike grass pollen allergy, there is no preventative treatment. Using blood cells from peanut-allergic patients, we will identify the components of major peanut allergens to use in _allergy shots� to develop tolerance on peanut exposure without risking anaphylaxis.
Anaphylaxis To Australian Native Ant Venoms; Major Allergens, Cross-reactivity, Diagnosis And Risk Assessment.
Funder
National Health and Medical Research Council
Funding Amount
$345,813.00
Summary
Insect venom allergy is a major cause of life-threatening allergy (anaphylaxis) in this country, and native ants are the most frequent cause in some regions. For introduced insects (bees and wasps), venom extracts are widely available for diagnostic and therapeutic use, but this is not yet the case for native ants. As many as 50,000 Australians may be affected by allergy to stings from ants in the native genus Myrmecia. This project will provide an in-depth understanding of the ant species respo ....Insect venom allergy is a major cause of life-threatening allergy (anaphylaxis) in this country, and native ants are the most frequent cause in some regions. For introduced insects (bees and wasps), venom extracts are widely available for diagnostic and therapeutic use, but this is not yet the case for native ants. As many as 50,000 Australians may be affected by allergy to stings from ants in the native genus Myrmecia. This project will provide an in-depth understanding of the ant species responsible for anaphylaxis in Australia. We will develop a range of diagnostic test modules, a detailed national map of causative species, and a panel of reference venoms and allergic sera, so that accurate diagnostic tests can be assured, and so that high quality venom extracts can be provided for human use (immunotherapy). We will also study allergic volunteers for up to five years, so as to determine which people are at the highest risk of repeated stings and reactions and thus most likely to benefit from desensitisation. Current evidence suggests that the commonest cause of native insect venom allergy may be the jack jumper ant Myrmecia pilosula, for which a desensitising venom extract has been developed and shown to be highly effective in preventing life threatening reactions. The research described in this application will enable doctors to ensure an accurate diagnosis, which is an essential step before desensitising treatment can be offered for jack jumper allergy. Another large group of people are probably allergic to larger Myrmecia known as bull dog ants or inch ants. Our results with regard to cross-reactivity patterns and venom similarities will enable us to determine an optimum therapeutic mixture of bull dog ant venoms and thus enable us to provide treatment for people allergic to these ants as well.Read moreRead less
Population Prevalence And Environmental-genetic Predictors Of Food Allergy In An Infant Cohort
Funder
National Health and Medical Research Council
Funding Amount
$551,642.00
Summary
This study will measure which children are at greatest risk of food allergy. We plan to recruit 5000 children to test for food allergies, as well as asking a range of questions on different lifestyle factors such as diet and history of allergies . If positive, participants will be invited to a hospital clinic for tests and treatment. This will allow us to describe the epidemiology of food allergy, and assist the development of better services for those with food allergy in the community.
Immunological And Molecular Basis Of Anaphylaxis Caused By Peanut And Tree Nut Allergy
Funder
National Health and Medical Research Council
Funding Amount
$195,691.00
Summary
An allergy to nuts is estimated to affect 1% of the population and peanuts are the major cause of fatal food-induced anaphylaxis. Five deaths occurred in the UK in 1993 which attracted media attention to the gravity of this problem. Proteins in the nut trigger a massive immunological reaction that causes the body to go into anaphylactic shock in which all the major body systems shut down. Nut allergy usually presents in infancy and persists indefinitely. As nuts are used in a wider and less visi ....An allergy to nuts is estimated to affect 1% of the population and peanuts are the major cause of fatal food-induced anaphylaxis. Five deaths occurred in the UK in 1993 which attracted media attention to the gravity of this problem. Proteins in the nut trigger a massive immunological reaction that causes the body to go into anaphylactic shock in which all the major body systems shut down. Nut allergy usually presents in infancy and persists indefinitely. As nuts are used in a wider and less visible range of food products, sensitisation is increasing and occurring earlier. It has been proposed, wrongly, that peanut (groundnut) allergic patients do not suffer from allergy to tree nuts (hazel, almond, Brazil, walnut). However a British survey of 1250 patients suffering from peanut anaphylaxis revealed that 50% of people with peanut allergy are also allergic to other nuts confirming our own clinical observations. At present, unlike insect venom allergy, grass pollen allergy and house dust mite allergy, there is no preventative treatment available. We plan to explore peanut allergy and investigate cross-reactivity between peanuts and major tree nuts to attempt to identify an allergen(s) that could explain the molecular nature of the allergy and offer approaches to immunotherapy. This information is necessary if we are to achieve safe and effective allergy shots for patients with this life long and life-threatening allergy as well as assisting in the development of better diagnosticRead moreRead less
Control Of SNARE-mediated Granule Fusion In Mast Cells
Funder
National Health and Medical Research Council
Funding Amount
$196,527.00
Summary
Asthma is an allergic disease affecting two million Australians. A major player in asthma is the mast cell which releases histamine when the cell is stimulated by antigen. The process by which histamine is released involves fusion of cytoplasmic granules containing the histamine with the cell surface membrane. The mechanism of this fusion process appears to be different in mast cells compared with other cells studied, raising the possibility that release of histamine, and hence the acute allergi ....Asthma is an allergic disease affecting two million Australians. A major player in asthma is the mast cell which releases histamine when the cell is stimulated by antigen. The process by which histamine is released involves fusion of cytoplasmic granules containing the histamine with the cell surface membrane. The mechanism of this fusion process appears to be different in mast cells compared with other cells studied, raising the possibility that release of histamine, and hence the acute allergic response, could be controlled if more were understood about the fusion process. This project aims to define the mechanism by which granules dock and then fuse with the cell surface. These are the two apects most likely to be unique in mast cells.Read moreRead less